Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Cellular senescence
Video summary

Webinar description: senescent cells, SASP and senolytic research

The description announces an educational webinar on cellular senescence, the senescence-associated secretory phenotype (SASP), and senotherapeutic strategies, naming senolytics such as dasatinib plus quercetin and fisetin and intermittent dosing. It states the webinar gives no medical advice. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The description says the webinar covers cellular senescence, its role in aging and chronic disease, and the SASP in inflammation and tissue damage. [1]

  2. The description names dasatinib plus quercetin and fisetin as senolytics in current research and mentions intermittent dosing strategies. [1]

  3. The description states the webinar is educational only and gives no medical advice or individualized treatment recommendations. [1]

The source at a glance

Study type / format
Video description of an educational webinar
Population / context
Audience named in the description: integrative health students, herbal medicine practitioners, nutrition professionals, longevity researchers, wellness practitioners and others interested in evidence-based healthy aging.
Summary based on
Creator description
Original publication
March 11, 2026

Announced topics on senescence and SASP

According to the description, the webinar covers what cellular senescence is and how it is said to contribute to aging and chronic disease. It also promises to distinguish beneficial short-term senescence from harmful lingering cells and to discuss the role of SASP in inflammation and tissue damage. These are announced topics, not reported results; the description gives no data, measurements or outcomes.

Supporting source [1]

Named senolytics and intermittent dosing

The description says current research on senolytics will be presented, naming dasatinib plus quercetin and fisetin, and that the science behind intermittent dosing strategies will be covered. It does not report study designs, doses, participants or results for these substances. The description also lists lifestyle, nutrition and metabolic health as topics said to support longevity.

Supporting source [1]

Stated audience and educational disclaimer

The description addresses integrative health students, herbal medicine practitioners, nutrition professionals, longevity researchers, wellness practitioners and others interested in evidence-based healthy aging. It states the webinar is for educational purposes only and provides no medical advice or individualized treatment recommendations.

Supporting source [1]

How to interpret this

Only the video description was available; the video and transcript were not reviewed. All content is attributed to the description, which announces topics without reporting study designs, data or outcomes.

Based on the creator’s description; the full video and transcript were not analyzed.

Source & supporting passages

[1]
Senescent Cells and Natural Anti-Senescent Molecules

achstv · youtube.com · March 11, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    the senescence-associated secretory phenotype (SASP)
  2. Finding 2 ↑

    Dasatinib + Quercetin and fisetin
  3. Finding 3 ↑

    does not provide medical advice

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…